Literature DB >> 27076596

A 380-gene meta-signature of active tuberculosis compared with healthy controls.

Simon Blankley1, Christine M Graham1, Joe Levin1, Jacob Turner2, Matthew P R Berry3, Chloe I Bloom1, Zhaohui Xu4, Virgina Pascual4, Jacques Banchereau5, Damien Chaussabel6, Ronan Breen7, George Santis8, Derek M Blankenship2, Marc Lipman9, Anne O'Garra10.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27076596      PMCID: PMC4892351          DOI: 10.1183/13993003.02121-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  16 in total

1.  Critical role of AIM2 in Mycobacterium tuberculosis infection.

Authors:  Hiroyuki Saiga; Shoko Kitada; Yosuke Shimada; Naganori Kamiyama; Megumi Okuyama; Masahiko Makino; Masahiro Yamamoto; Kiyoshi Takeda
Journal:  Int Immunol       Date:  2012-06-13       Impact factor: 4.823

2.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus.

Authors:  Damien Chaussabel; Charles Quinn; Jing Shen; Pinakeen Patel; Casey Glaser; Nicole Baldwin; Dorothee Stichweh; Derek Blankenship; Lei Li; Indira Munagala; Lynda Bennett; Florence Allantaz; Asuncion Mejias; Monica Ardura; Ellen Kaizer; Laurence Monnet; Windy Allman; Henry Randall; Diane Johnson; Aimee Lanier; Marilynn Punaro; Knut M Wittkowski; Perrin White; Joseph Fay; Goran Klintmalm; Octavio Ramilo; A Karolina Palucka; Jacques Banchereau; Virginia Pascual
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

Review 3.  Type I interferons in infectious disease.

Authors:  Finlay McNab; Katrin Mayer-Barber; Alan Sher; Andreas Wack; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2015-02       Impact factor: 53.106

4.  Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.

Authors:  Chloe I Bloom; Christine M Graham; Matthew P R Berry; Katalin A Wilkinson; Tolu Oni; Fotini Rozakeas; Zhaohui Xu; Jose Rossello-Urgell; Damien Chaussabel; Jacques Banchereau; Virginia Pascual; Marc Lipman; Robert J Wilkinson; Anne O'Garra
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

5.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

Review 6.  The immune response in tuberculosis.

Authors:  Anne O'Garra; Paul S Redford; Finlay W McNab; Chloe I Bloom; Robert J Wilkinson; Matthew P R Berry
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

7.  Compensatory dendritic cell development mediated by BATF-IRF interactions.

Authors:  Roxane Tussiwand; Wan-Ling Lee; Theresa L Murphy; Mona Mashayekhi; Wumesh KC; Jörn C Albring; Ansuman T Satpathy; Jeffrey A Rotondo; Brian T Edelson; Nicole M Kretzer; Xiaodi Wu; Leslie A Weiss; Elke Glasmacher; Peng Li; Wei Liao; Michael Behnke; Samuel S K Lam; Cora T Aurthur; Warren J Leonard; Harinder Singh; Christina L Stallings; L David Sibley; Robert D Schreiber; Kenneth M Murphy
Journal:  Nature       Date:  2012-09-19       Impact factor: 49.962

8.  Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.

Authors:  Chloe I Bloom; Christine M Graham; Matthew P R Berry; Fotini Rozakeas; Paul S Redford; Yuanyuan Wang; Zhaohui Xu; Katalin A Wilkinson; Robert J Wilkinson; Yvonne Kendrick; Gilles Devouassoux; Tristan Ferry; Makoto Miyara; Diane Bouvry; Dominique Valeyre; Valeyre Dominique; Guy Gorochov; Derek Blankenship; Mitra Saadatian; Phillip Vanhems; Huw Beynon; Rama Vancheeswaran; Melissa Wickremasinghe; Damien Chaussabel; Jacques Banchereau; Virginia Pascual; Ling-Pei Ho; Marc Lipman; Anne O'Garra
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis.

Authors:  Simone A Joosten; Helen A Fletcher; Tom H M Ottenhoff
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

Review 10.  The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis.

Authors:  Simon Blankley; Matthew Paul Reddoch Berry; Christine M Graham; Chloe I Bloom; Marc Lipman; Anne O'Garra
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

View more
  28 in total

1.  Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Steven A Cowman; Joseph Jacob; David M Hansell; Peter Kelleher; Robert Wilson; William O C Cookson; Miriam F Moffatt; Michael R Loebinger
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

2.  Single-cell RNA-sequencing of peripheral blood mononuclear cells reveals widespread, context-specific gene expression regulation upon pathogenic exposure.

Authors:  Roy Oelen; Dylan H de Vries; Harm Brugge; M Grace Gordon; Martijn Vochteloo; Chun J Ye; Harm-Jan Westra; Lude Franke; Monique G P van der Wijst
Journal:  Nat Commun       Date:  2022-06-07       Impact factor: 17.694

Review 3.  Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.

Authors:  Jan Heyckendorf; Sophia B Georghiou; Nicole Frahm; Norbert Heinrich; Irina Kontsevaya; Maja Reimann; David Holtzman; Marjorie Imperial; Daniela M Cirillo; Stephen H Gillespie; Morten Ruhwald
Journal:  Clin Microbiol Rev       Date:  2022-03-21       Impact factor: 50.129

4.  Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis.

Authors:  Julie G Burel; Cecilia S Lindestam Arlehamn; Nabeela Khan; Grégory Seumois; Jason A Greenbaum; Randy Taplitz; Robert H Gilman; Mayuko Saito; Pandurangan Vijayanand; Alessandro Sette; Bjoern Peters
Journal:  J Immunol       Date:  2018-03-30       Impact factor: 5.422

5.  Association of the TLR1 variant rs5743557 with susceptibility to tuberculosis.

Authors:  Miaomiao Zhang; Jing Wang; Yu Wang; Shouquan Wu; Andrew J Sandford; Jun Luo; Jian-Qing He
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

6.  Transfer transcriptomic signatures for infectious diseases.

Authors:  Julia di Iulio; Istvan Bartha; Roberto Spreafico; Herbert W Virgin; Amalio Telenti
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

7.  Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis.

Authors:  Hanif Esmail; Rachel P Lai; Maia Lesosky; Katalin A Wilkinson; Christine M Graham; Stuart Horswell; Anna K Coussens; Clifton E Barry; Anne O'Garra; Robert J Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

Review 8.  The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis.

Authors:  Akul Singhania; Robert J Wilkinson; Marc Rodrigue; Pranabashis Haldar; Anne O'Garra
Journal:  Nat Immunol       Date:  2018-10-17       Impact factor: 25.606

9.  Human Genomics of Mycobacterium tuberculosis Infection and Disease.

Authors:  Marianna Orlova; Erwin Schurr
Journal:  Curr Genet Med Rep       Date:  2017-07-25

10.  Doxycycline host-directed therapy in human pulmonary tuberculosis.

Authors:  Qing Hao Miow; Andres F Vallejo; Yu Wang; Jia Mei Hong; Chen Bai; Felicia Sw Teo; Alvin Dy Wang; Hong Rong Loh; Tuan Zea Tan; Ying Ding; Hoi Wah She; Suay Hong Gan; Nicholas I Paton; Josephine Lum; Alicia Tay; Cynthia Be Chee; Paul A Tambyah; Marta E Polak; Yee Tang Wang; Amit Singhal; Paul T Elkington; Jon S Friedland; Catherine Wm Ong
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.